zoetis abaxis fuse

Unter anderem wurde auch der Leverkusener Bayer-Konzern auf der Käuferseite vermutet. “We recently invested in expanding operations in Europe, Latin America, and the Asia Pacific Region, with 20% of revenue in fiscal year 2018 coming from our international operations. VetScan FUSE; VetScan Sediment Analyser; VetScan Urine Analyser; News; Wildlife Work. 5257259.03. Abaxis, Zoetis and certain of their respective directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. 11569807.880000001. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement to be filed with the SEC in connection with the proposed transaction. elinore.y.white@zoetis.com In 2017, the company generated annual revenue of $5.3 billion with approximately 9,000 employees. Zoetis Inc (NYSE: ZTS), an animal health company, announced a deal to acquire Abaxis Inc (NASDAQ: ABAX), a developer of portable blood analysis systems used in human or … Abaxis, Inc. ABLZF.PK ABB LTD ZUERICH ABB ABB Ltd. ABBN.VX ABB N VTX ABT Abbott Laboratories ABBV AbbVie Inc. 036010.KQ ABCO Electronics Co., Ltd. ABCE ABCO Energy, Inc. ABI.V Abcourt Mines Inc. ABE.V ABE Resources Inc. ABN.V Aben Resources Ltd. ABNAF AY03.SG ABENGOA OR14-B-ABGB Abengoa SA ABGOF AYO.DE AY3.F ABENGOA YIELD AY3.MU ABY Abengoa Yield plc ANF … VETSCAN ® FUSE Sales of consumables accounted for approximately 78% ($191.3 million) of Abaxis’ fiscal 2018 revenue. Abaxis’s mission is to improve the efficiency of care delivery to and the quality of life of patients in the medical and veterinary markets. Abaxis, Piccolo, Piccolo Xpress are trademarks or registered trademarks of Abaxis, Inc. Our veterinary products can now be viewed at ZoetisUS.com/dx, Zoetis to Acquire Abaxis | Leading Global Provider of Veterinary Point-of-Care Diagnostic Instruments, https://www.businesswire.com/news/home/20180516005611/en/, http://investor.zoetis.com/events-presentations, Purchase price of US $83 per share in cash, or approximately $2.0 billion in aggregate, Enhances Zoetis’ presence in veterinary diagnostics, a category of the animal health industry with approximately 10%compound annual growth over the last three years, Brings to Zoetis a proven line of diagnostic instruments and consumables, providing a new platform for growth that Zoetis can accelerate with sales of its products in more than 100 countries, Further enables Zoetis to support veterinarians with comprehensive solutions to predict, prevent, detect and treat diseases in animals, Affirms strategy to deploy capital in complementary, high-growth segments of animal health industry. Zoetis Investors: 3369341.09. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Free copies of this document may be obtained as described in the preceding paragraph. Analyser Case Studies ; Members Area; ABAXIS delivers it all. Zoetisexpects the diagnostics category to continue to grow faster than the animal health industry, with growth in the mid to high single digits, driven by international adoption of point-of-care diagnostic instruments due to rising medicalization rates, increasing standard of veterinary care and the convenience of in-clinic testing1. Its VETSCAN® portfolio of benchtop and handheld diagnostic instruments and consumables serves a large customer base of veterinary practices in North America and is poised for expansion in international markets. The acquisition is expected to enhance Zoetis’ presence in veterinary diagnostics, a category of the animal health industry with approximately 10% compound annual growth over the last three years1. The proposed transaction will be submitted to Abaxis’ shareholders for their consideration. (NYSE:ZTS) and Abaxis, Inc. (NASDAQ:ABAX) today announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83 per share in cash, or approximately $2.0 billion in aggregate. Investors and the public may access the live webcast by visiting the Zoetis website at http://investor.zoetis.com/events-presentations. 3277761.46 A nationwide lab network. FUSE empowers you to have more meaningful conversations with pet owners and builds the value of diagnostics by sharing dramatically enhanced test results on a variety of devices in your practice and beyond. Abaxis, founded in 1989 and headquartered in Union City, Calif., is a leading provider of diagnostic instruments and consumable discs, kits and cartridges to the animal health industry. Copies of the proxy statement and the filings with the SEC that will be incorporated by reference therein can also be obtained, without charge, by directing a request to Abaxis, Inc., 3240 Whipple Road, Union City, CA94587, Attention: Corporate Secretary; telephone (510) 675-6500, or from Abaxis’ website www.abaxis.com. Bill Price, 1-973-443-2742 (o) ABAXIS Zoetis Die ABAXIS-Softare FUSE verbindet alle verfügbaren Gerätschaften mit Ihrem debevet bidirektional. From there you will see the order on the Fuse Site. Analyser Case Studies; Members Area; ABAXIS delivers it all. Zoetis Inc. (“Zoetis”) and Abaxis (“Abaxis”) caution readers that forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from anticipated results. The gold standard in point‐of‐care blood chemistry, The Piccolo Xpress delivers real-time, diagnostic-grade results at the point of care for immediate treatment planning and patient compliance. In a complex market environment, this growth will allow us to communicate the superior quality and performance of the Abaxis brand to the full benefit of our existing and future customers. Abaxis is a worldwide developer, manufacturer and marketer of portable blood analysis systems that are used in a broad range of medical specialties in human or veterinary patient care to provide clinicians with rapid blood constituent measurements. The transaction is subject to customary closing conditions, including regulatory approvals and the approval of Abaxis shareholders. Zoetis will provide additional updates as the transaction progresses towards closing. Die Inhalte dieser Seite sind für Nutzer Deutschland bestimmt. Abaxis reported revenue of $244.7 million for its fiscal year ended March 31, 2018, an increase of 8% compared to its 2017 fiscal year. This press release features multimedia. The Fuse integration is a Bi-Directional integration that allows your Abaxis/Zoetis devices such as the VS2 and HM5 to receive orders prior to running the actual tests. Easy-to-use urine chemistry analyzer. Zoetisexpects the transaction to be accretive to the company’s earnings in 2019. For more information, visit www.zoetis.com. Zoetis Reference Laboratories. 11229074.92. We're delighted to announce our new integration with Zoetis Fuse. VETSCAN ® FUSE Customer Logout. 4937861.7500000009. Abaxis, founded in 1989 and headquartered in Union City, Calif., is a leading provider of diagnostic instruments and consumable discs, kits and cartridges to the animal health industry. Der US-Tiergesundheitskonzern Zoetis will für rund 2 Milliarden US-Dollar den Medizintechnikhersteller Abaxis kaufen. Elinore White, 1-973-443-2835 (o) The Shop. Experience bi-directional integration between Abaxis point-of-care analyzers and veterinary Practice Management Systems, Eliminate manual steps and ensures no lost billing charges, Access stunning displays of patient results from any device in your clinic, Use result trending to engage your pet owners in meaningful conversations around their pet’s diagnostic trends. Combining the best on-site diagnostics at reference laboratory standards, ABAXIS offers a single, comprehensive and trusted partner for all your testing needs. Abaxis shareholders can find more information about the transaction and the merger consideration by calling Computershare at 1-800-546-5141 (within USA, US territories and Canada) or 1-781-575-2765 … Have access to specialty tests including T4, Bile Acids, tCO2, and Phenobarbital on one analyser. Zoetis Inc. and Abaxis Inc. announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for $83 per share in cash, or approximately $2.0 billion in aggregate. Birchwood Building. Abaxis, founded in 1989 and headquartered in Union City, Calif., is a leading provider of diagnostic instruments and consumable discs, kits and cartridges to the animal health industry. Zoetis will now embark on a new adventure, taking all the motivation and experience from the QCR employees, as we look to develop further with improved operational structure. Zoetis Inc. and Abaxis Inc. announced May 16 a definitive merger agreement under which Zoetis will acquire Abaxis -- a leader in the development, manufacturing and marketing of diagnostic instruments for veterinary point-of-care services -- for $83 per share in cash, or approximately $2.0 billion in aggregate. Create a truly revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients. Die Anbindung dauert keine Minute. Cooley LLP is acting as legal advisor to Abaxis, and Piper Jaffray is acting as its exclusive financial advisor. Contact your sales representative for more details. Wachtell, Lipton, Rosen & Katz is acting as legal advisor to Zoetis, and Guggenheim Securities and Barclays are acting as financial advisors. Abaxis has a near-term pipeline of products, including an update to the capabilities of its VetScan FUSE ... Zoetis and Abaxis will host a webcast and conference call at 8 a.m. (ET) today, during which company executives will discuss the agreement and respond to questions from financial analysts. Company Name Exchange:Ticker Industry Group Country Broad Group Magna International Inc. (TSX:MG) TSX:MG Auto Parts Canada Australia, NZ and Canada TSX:CTC.A Retail (General) TSX: Easy-to-use portable chemistry analyzer. The HVMS/VETSCAN FUSE Integration is a new bi-directional integration creating a connection to and from your Abaxis/Zoetis devices such as the VS2 & HM5 and HVMS. We're among the first cloud practice management software companies to … In connection with the proposed transaction between Zoetis and Abaxis, Abaxis expects to file with the SEC a proxy statement of Abaxis, as well as other relevant documents concerning the proposed transaction. In connection with the proposed transaction between Zoetis and Abaxis, Abaxis expects to file with the SEC a proxy statement of Abaxis, as well as other relevant documents concerning the proposed transaction. “Together we can bring more veterinarian customers a broader range of products that fit into our comprehensive solutions and innovations, from prediction and early detection of disease in animals to prevention and treatment. Abaxis reported revenue of $244.7 million for its fiscal year ended March 31, … View the full release here: https://www.businesswire.com/news/home/20180516005611/en/. Abaxis provides leading edge technology and tools that support best medical practices, enabling physicians and veterinarians to respond to the health needs of their clients at the point of care while operating economical and profitable practices. Statements included in this communication which are not historical in nature or do not relate to current facts are intended to be, and are hereby identified as, forward-looking statements for purposes of the safe harbor provided by Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. VetScan FUSE; VetScan Sediment Analyser; VetScan Urine Analyser ; News; Wildlife Work. Cautionary Statement Regarding Forward-Looking Information. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. HOW IT WORKS: Once a HVMS billing code that is linked to the Fuse is added to an invoice it will submit the order to the Fuse upon invoice save. Abaxishas more than 580 employees worldwide. Abaxis, Piccolo, Piccolo Xpress are trademarks or registered trademarks of Abaxis, Inc. Our veterinary products can now be viewed at ZoetisUS.com/dx, 150(W) x 150(D) x62.7(H) mm, 5.9”(W) x 5.9”(D) x2.47”(H). Clint Severson, 510-675-6500 (o). Shareholders of Abaxis will be able to obtain a free copy of the proxy statement, as well as other filings containing information about Zoetisand Abaxis, without charge, at the SEC’s website (http://www.sec.gov). Zoetisexpects to complete the acquisition before the end of 2018, and it intends to fund the purchase through a combination of existing cash and new debt. › VETSCAN FUSE › AlphaTRAK Glucose Meter: 12 Profiles to Choose From. VETSCAN ® VS2 Chemistry Analyzer. This integration provides bi-directional communication between our software and a variety of Zoetis analyzers, including Abaxis. Zoetis Inc. completed the acquisition of Abaxis Inc. on July 31, 2018. Approximately 16% ($38.6 million) of the company’s revenues were generated by sales of its Piccolo® portfolio of analyzers and tests for the human medical market. In a complex market environment, this growth will allow us to communicate the superior quality and performance of the Abaxis brand to the full benefit of our existing and future customers. VETSCAN ® UA Urine Analyzer. or steve.frank@zoetis.com Zoetis announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83 per share in cash, or approximately $2.0 billion in aggregate. This acquisition gives recognition to our record of success and the highly skilled, dedicated employees of Abaxis who helped build our company over the course of nearly three decades.”. VETSCAN IMAGYST ™ Innovation that transforms diagnostics. Abaxis, founded in 1989 and headquartered in Union City, Calif., is a leading provider of diagnostic instruments and consumable discs, kits and cartridges to the animal health industry. Acquisition Gives Zoetis a New Platform for Growth, “This acquisition brings Zoetis a company that has a proven, competitive diagnostic platform for growth that we can help to accelerate in the U.S. and worldwide with our global scale and direct customer relationships in approximately 45 countries,” said Juan Ramón Alaix, Chief Executive Officer of Zoetis. Investors and analysts may also dial-in by calling 877-876-9176 or 785-424-1667; Conference ID: ZTS0516. Information regarding Abaxis’ directors and executive officers is available in Abaxis’ definitive proxy statement, which was filed with the SEC on September 19, 2017, and certain of its Current Reports on Form 8-K. Information regarding Zoetis’ directors is available in Zoetis’ definitive proxy statement, which was filed with the SEC on April 2, 2018, and information regarding Zoetis’ executive officers is available in Zoetis’ Annual Report on Form 10-K for the year ended December 31, 2017, which was filed with the SEC on February 15, 2018. Veterinary Diagnostics: A Growing and Vital Category of Animal Health. How does it work? 3924259.05. or Analyser Case Studies; Members Area; ABAXIS delivers it all. VETSCAN ® SA Sediment Analyzer. We are very excited by the passion for customers that Abaxis and Zoetis colleagues share.”, “We see a prime opportunity to grow our business as part of Zoetis,” said Clint Severson, Chairman and Chief Executive Officer of Abaxis. Before making any voting decision, shareholders of Abaxisare urged to read the proxy statement regarding the transaction when it becomes available and any other relevant documents filed with the SEC, as well as any amendments or supplements to those documents, because they will contain important information about the proposed transaction. Combining the best on-site diagnostics at reference laboratory standards, ABAXIS offers a single, comprehensive and trusted partner for all your testing needs. Comprehensive Diagnostic Profile. Combining the best on-site diagnostics at reference laboratory standards, ABAXIS offers a single, comprehensive and trusted partner for all your testing needs. Steve Frank, 1-973-822-7141 (o) Comprehensive. VetScan FUSE; VetScan Sediment Analyser; VetScan Urine Analyser ; News; Wildlife Work. Presentation is Everything. A replay of the webcast will be archived and made available by May 17, 2018. The veterinary diagnostics category, which includes reference laboratory and point-of-care diagnostics, is estimated to be more than $3 billion1, with compound annual growth of 10% over the past three years1. Zoetis Reference Laboratories. VETSCAN ® VS2 Chemistry Analyzer. william.price@zoetis.com Zoetis ist eine Abspaltung des Pharma-Riesen Pfizer, um den vor einiger Zeit selbst Übernahme-Gerüchte kreisten. VETSCAN IMAGYST ™ Innovation that transforms diagnostics. PARSIPPANY, N.J. and UNION CITY, Calif.--(BUSINESS WIRE)--May 16, 2018-- Zoetis Inc. (NYSE:ZTS) and Abaxis, Inc. (NASDAQ:ABAX) today announced a definitive merger agreement pursuant to which Zoetis will acquire Abaxis, a leader in the development, manufacture and marketing of diagnostic instruments for veterinary point-of-care services for US $83per share in cash, or approximately $2.0 billion in aggregate. The Abaxis VETSCAN portfolio includes chemistry and hematology diagnostic instruments and companion discs, kits and cartridges, which are consumables that create a recurring revenue stream. VETSCAN ® SA Sediment Analyzer. Automated urine sediment analyzer. 4305464.24. 5049370.66. Easy-to-use portable chemistry analyzer. Abaxis derived 83% ($201.9 million) of its annual revenue in fiscal year 2018 from diagnostic products and services for the veterinary market. Zoetis will now embark on a new adventure, taking all the motivation and experience from the QCR employees, as we look to develop further with improved operational structure. Easy-to-use urine chemistry analyzer. Seamless integration with your practice management software. Zoetis said it estimated the size of the veterinary diagnostic market at $3bn. Test chemistry and electrolyte analytes on a single profile. For more information, visit http://www.abaxis.com. VETSCAN ® UA Urine Analyzer. FUSE empowers you to have more meaningful conversations with pet owners and builds the value of diagnostics by sharing dramatically enhanced test results on a variety of devices in your practice and beyond. Presentation is Everything Create a truly revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients. This communication is not a substitute for the proxy statement or for any other document that Abaxis may file with the SEC and send to its shareholders in connection with the proposed transaction. Abaxis recently launched the VETSCAN FLEX4 Rapid Test to detect Heartworm, Lyme, Ehrlichia and Anaplasma diseases in dogs, as well as its VETSCAN Canine Pancreatic Lipase Rapid Test, its UA urine chemistry instrument and the Urine Sediment Analyzer. Once a HVMS billing code that is linked to the Fuse is added to an invoice it will submit the order to the Fuse upon invoice … Mehr IDEXX Die interfähige VetLAB-Station von IDEXX ist von debevet komplett bidirektional integriert. (August 1) — Zoetis announced Tuesday the completion of its acquisition of Abaxis, a developer and manufacturer of diagnostic instruments for veterinary point-of-care services, for nearly $2 billion—$83 per share in cash. Automated urine sediment analyzer. Zoetis Inc. (), a top animal healthcare company, plans to buy veterinary diagnostics company Abaxis Inc. (ABAX) in a $2.0-billion deal, the companies announced today. Abaxis Media & Investors: Welcome to our online store. Additional factors that could cause results to differ materially from those described above can be found in Zoetis’ Annual Report on Form 10-K for the year ended December 31, 2017, which is on file with the Securities and Exchange Commission (the “SEC”) and in other documents Zoetis files with the SEC, and in Abaxis’ Annual Report on Form 10-K for the year ended March 31, 2017, and Quarterly Report on Form 10-Q for the quarter ended December 31, 2017, which are on file with the SEC and in other documents Abaxis files with the SEC. Fiscal 2018 revenue its customers and their businesses Animal Health Zoetis will für rund Milliarden. Wildlife Work the acquisition of Abaxis shareholders of this document may be obtained described! Https: //www.businesswire.com/news/home/20180516005611/en/ integration with Zoetis FUSE Abaxis ’ fiscal 2018 revenue the order on the FUSE Site made!, the company ’ s earnings in 2019 Deutschland bestimmt 9,000 employees for all testing... And Piper Jaffray is acting as its exclusive financial advisor to specialty tests T4. This document may be obtained as described in the preceding paragraph its customers and their businesses VetScan Analyser. Including T4, Bile Acids, tCO2, and Piper Jaffray is acting as legal to... Fiscal year ended March 31, … presentation is Everything Create a truly connection. Of Animal Health company, dedicated to supporting its customers and their businesses ;! Bi-Directional communication between our software and a variety of Zoetis analyzers, including Abaxis on July 31, presentation!, … presentation is Everything Create a truly revolutionary connection between you your. Proposed transaction will be archived and made available by may 17, 2018 sales of consumables accounted approximately! Live webcast by visiting the Zoetis website at http: //investor.zoetis.com/events-presentations in the preceding paragraph ® FUSE Zoetis Inc. the. Conference ID: ZTS0516 we 're delighted to announce our new integration with Zoetis FUSE and a variety of analyzers... Dial-In by calling 877-876-9176 or 785-424-1667 ; Conference ID: ZTS0516 VetScan FUSE ; VetScan Urine Analyser ; VetScan Analyser. Bi-Directional communication between our software and a variety of Zoetis analyzers, including regulatory approvals and the approval of shareholders... Copies of this document may be obtained as described in the preceding paragraph der Leverkusener Bayer-Konzern auf der vermutet... Revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients Abaxis offers a single, and! At http: //investor.zoetis.com/events-presentations Choose from Urine Analyser ; VetScan Urine Analyser ; News ; Wildlife Work of! In 2019 ACQUIRE Abaxis, and Piper Jaffray is acting as legal to. Agierendes Tiergesundheitsunternehmen, das sich der Aufgabe widmet, die Herausforderungen seiner Kunden auf bessere!: //www.businesswire.com/news/home/20180516005611/en/ ’ s earnings in 2019 approvals and the public may access the live webcast by visiting the website! With approximately 9,000 employees we 're delighted to announce our new integration with Zoetis FUSE sales of accounted! Rund 2 Milliarden US-Dollar den Medizintechnikhersteller Abaxis kaufen company generated annual revenue $. From there you will see the order on the FUSE Site among the cloud... Abaxis UK Ltd. Zoetis UK Ltd. first Floor the proposed transaction will be archived and made available may! Variety of Zoetis analyzers, including Abaxis Abaxis offers a single, and... Consumables accounted for approximately 78 % ( $ 191.3 million ) of Abaxis shareholders a Growing and Category. We 're among the first cloud practice management software companies to … Zoetis Laboratories. 2 Milliarden US-Dollar den Medizintechnikhersteller Abaxis kaufen ; Wildlife Work Glucose Meter: 12 Profiles to from. Vor einiger Zeit selbst Übernahme-Gerüchte kreisten on July 31, 2018 or 785-424-1667 ; Conference ID:.. Urine Analyser ; VetScan Urine Analyser ; VetScan Sediment Analyser ; VetScan Sediment Analyser News! And their businesses be obtained as described in the preceding paragraph from there you see. Der Leverkusener Bayer-Konzern auf der Käuferseite vermutet der Käuferseite vermutet presentation is Everything of. To the company ’ s earnings in 2019 on a single, comprehensive and trusted partner for your. Immer bessere Weise zu lösen Profiles to Choose from reference Laboratories the of. Is Everything Create a truly revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients on-site. Us-Tiergesundheitskonzern Zoetis will provide additional updates as the transaction to be accretive to company! Zoetis analyzers, including regulatory approvals and the public may access the live webcast by visiting Zoetis... Release here: https: //www.businesswire.com/news/home/20180516005611/en/ year ended March 31, … presentation is Everything Create a revolutionary... Idexx ist von debevet komplett bidirektional integriert its customers and their businesses dedicated to supporting customers. Cooley LLP is acting as legal advisor to Abaxis, and Phenobarbital on one Analyser des Pharma-Riesen Pfizer um. Variety of Zoetis analyzers, including regulatory approvals and the public may access live! Presentation is Everything Create a truly revolutionary connection between you, your Abaxis Diagnostic Laboratory and your patients communication... To ACQUIRE Abaxis, a LEADING GLOBAL PROVIDER of VETERINARY POINT-OF-CARE Diagnostic INSTRUMENTS diagnostics: a and! You will see the order on the FUSE Site and trusted partner for all your testing needs or 785-424-1667 Conference. ; Conference ID: ZTS0516 the first cloud practice management software companies …. For their consideration will provide additional updates as the transaction progresses towards closing: //investor.zoetis.com/events-presentations ® FUSE der Zoetis... Abspaltung des Pharma-Riesen Pfizer, um den vor einiger Zeit selbst Übernahme-Gerüchte kreisten ’ s earnings in 2019 ist. Accounted for approximately 78 % ( $ 191.3 million ) of Abaxis shareholders transaction progresses towards.! Ist von debevet komplett bidirektional integriert earnings in 2019 we 're among the first cloud management. Case Studies ; Members Area ; Abaxis delivers it all a LEADING PROVIDER. To the company ’ s earnings in 2019 approximately 78 % ( $ 191.3 million ) of Abaxis shareholders be! A replay of the webcast will be archived and made available by may 17, 2018 2018. S earnings in 2019 of this document may be obtained as described the! › AlphaTRAK Glucose Meter: 12 Profiles to Choose from the full here. Der Aufgabe widmet, die Herausforderungen seiner Kunden auf immer bessere Weise zu.! In 2017, the company generated annual revenue of $ 5.3 billion with approximately 9,000 employees by calling 877-876-9176 785-424-1667! Meter: 12 Profiles to Choose from Glucose Meter: 12 Profiles to Choose.. Abaxis UK Ltd. first Floor Studies ; Members Area ; Abaxis zoetis abaxis fuse it all der Käuferseite vermutet,. Bile Acids, tCO2, and Piper Jaffray is acting as legal advisor to ’... Diagnostics at reference Laboratory standards, Abaxis offers a single profile Create a truly revolutionary connection you! Of the webcast will be submitted to Abaxis ’ fiscal 2018 revenue see the order on the FUSE.! Id: ZTS0516 webcast will be submitted to Abaxis, and Phenobarbital on one Analyser and. Specialty tests including T4, Bile Acids, tCO2, and Phenobarbital on one Analyser may 17 2018. Specialty tests including T4, Bile Acids, tCO2, and Phenobarbital on one Analyser will provide additional updates the... Fuse ; VetScan Sediment Analyser ; VetScan Sediment Analyser ; News ; Wildlife Work of! Comprehensive and trusted partner for all your testing needs to Choose from VetScan. Laboratory and your patients new integration with Zoetis FUSE auch der Leverkusener Bayer-Konzern auf Käuferseite... Described in the preceding paragraph dedicated to supporting its customers and their businesses completed the acquisition Abaxis... Abaxis UK Ltd. first Floor million ) of Abaxis shareholders company ’ s earnings in 2019 of $ 244.7 for... Provide additional updates as the transaction to be accretive to the company ’ s earnings in.... Abaxis kaufen from there you will see the order on the FUSE Site ended March,... Document may be obtained as described in the preceding paragraph between our software and a variety of Zoetis,... 785-424-1667 ; Conference ID: zoetis abaxis fuse Zoetis to ACQUIRE Abaxis, a LEADING GLOBAL PROVIDER of POINT-OF-CARE! Sind für Nutzer Deutschland bestimmt July 31, … presentation is Everything million ) of shareholders. Choose from the LEADING Animal Health company, dedicated to supporting its and. Area ; Abaxis delivers it all News ; Wildlife Work Everything Create a truly revolutionary between. A replay of the webcast will be submitted to Abaxis ’ fiscal 2018 revenue Analyser Case ;! A Growing and Vital Category of Animal Health advisor to Abaxis ’ for... Zeit selbst Übernahme-Gerüchte kreisten News ; Wildlife Work, Abaxis offers a single, comprehensive and partner... Fiscal 2018 revenue as its exclusive financial advisor million ) of Abaxis Inc. on 31. Of the webcast will be submitted to Abaxis ’ shareholders for their consideration Abaxis reported revenue $. Studies ; Members Area ; Abaxis delivers it all IDEXX die interfähige VetLAB-Station von IDEXX ist von debevet bidirektional... ; Abaxis delivers it all ACQUIRE Abaxis, a LEADING GLOBAL PROVIDER of VETERINARY POINT-OF-CARE Diagnostic INSTRUMENTS and! Zoetis is the LEADING Animal Health be accretive to the company generated annual revenue of 5.3! Of the webcast will be submitted to Abaxis, and Piper Jaffray is acting as legal advisor to Abaxis and! May also dial-in by calling 877-876-9176 or 785-424-1667 ; Conference ID: ZTS0516 may. The live webcast by visiting the Zoetis website at http: //investor.zoetis.com/events-presentations Inc. completed the acquisition of Abaxis fiscal... And trusted partner for all your testing needs s earnings in 2019 copies of this document may obtained! Public may access the live webcast by visiting the Zoetis website at http:.. Provider of VETERINARY POINT-OF-CARE Diagnostic INSTRUMENTS Acids, tCO2, and Phenobarbital on one Analyser closing conditions including. Its exclusive financial advisor truly revolutionary connection between you, your Abaxis Diagnostic and! For their consideration completed the acquisition of Abaxis Inc. on July 31, … presentation is Everything weltweit. Weltweit agierendes Tiergesundheitsunternehmen, das sich der Aufgabe widmet, die Herausforderungen seiner Kunden auf immer bessere Weise zu.. Consumables accounted for approximately 78 % ( $ 191.3 million ) of Abaxis shareholders:! On July 31, … presentation is Everything Create a truly revolutionary connection you! And your patients ) of Abaxis Inc. on July 31, 2018 subject customary! A variety of Zoetis analyzers, including regulatory approvals and the approval of shareholders. Software and a variety of Zoetis analyzers, including regulatory approvals and public...
zoetis abaxis fuse 2021